HHS reg reform
Executive Summary
HHS is asking the public to suggest federal health care regulations that "could be coordinated and simplified to reduce costs and burdens and improve the translation of biomedical research into medical practice," according to an Oct. 4 1Federal Register notice from the HHS Assistant Secretary for Planning & Evaluation. Responding to a congressional directive, HHS and the White House Office of Management & Budget will establish an interagency committee to examine major federal regulations that affect the health care industry and make suggestions for how they can be reformed. As part of the process, a series of public meetings will be held to gather comments from stakeholders, including patients, practitioners and health care administrators...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.